Growing Awareness about Food Allergy Driving Anaphylaxis Treatment: Fact.MR

Investments towards promotion of fertility treatment services aimed towards international clients is likely to remain key to growth strategies in terms of sales in a fairly competitive industry.

Fact.MR, Rockville MD: An ongoing report on the anaphylaxis treatment market published by market research company Fact.MR has projected very strong growth prospects through 2021 and further. The covid-19 pandemic has created opportunities for the anaphylaxis treatment industry owing to known risks of allergic reactions arising from the administration of varied covid-19 vaccine dosages. The market is likely to witness a gradual recovery through 2021, as governments are relaxing lockdown restrictions towards elective medical procedures.

According to a report by the World Allergy Organization, up to 77 people out of every 100,000 around the world are inflicted by anaphylaxis. Also, estimated prevalence rates range from 2% in the United States of America, to 0.1% in Korea, and between 0.6 to 1% of the population in Australia. Improvements to the reimbursement scenario, and better health awareness in low- and middle-income countries generate opportunities for anaphylaxis treatment.

Anaphylaxis, and fatalities from the condition, are reported to be more common in adults as compared to children. Deaths from anaphylaxis primarily occur among adults, followed by children in the under the age of 5, and then in adolescents. This is a key trend that will affect long term developments in the industry.

“The introduction of generic auto injector products in the anaphylaxis treatment market is expected to generate highly lucrative growth opportunities for investors in the sector due to increasing interest from private insurance providers. Improvements to reimbursement schemes and reduced coverage on cost prohibitive auto injectors while covering affordable generics will positively influence the long-term sales prospects in the industry,” comments a Fact.MR analyst.

Request a report sample to gain detailed insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=3417

Key Takeaways from Fact.MR’s Anaphylaxis Treatment Market

  • Epinephrine dosage treatments remain a popular treatment choice for manufacturers in the sector owing to fast-acting efficacy.
  • Oral treatment options are gaining ground at a faster rate owing to ease of administration and improvements to patient outcomes.
  • Food allergy applications will remain a key contributor to demand owing to poor lifestyle and diet choices and increasing awareness among patients.
  • Drug stores will reflect strong growth owing to ease of access to patients, and improvements to product design for home use.
  • The United States will reflect strong growth better patient awareness, and facilities for early diagnostics.
  • China and India will emerge has lucrative markets owing to improving awareness in urban areas.

Anaphylaxis Treatment Market – Prominent Drivers

  • Growing innovations in drug delivery devices and materials are key contributors to demand in the market.
  • Changes in lifestyle and food habits influence incidences of allergic reactions creating opportunities in the industry.
  • Investments by governments in emerging economies towards advanced diagnostics will bolster the anaphylaxis treatment market.

Anaphylaxis Treatment Market – Key Restraints

  • High prices associated with branded products is a key factor holding back anaphylaxis treatment adoption.
  • Lack of awareness about the usage of auto injector products in the industry hurt sales and adoption.

Discover more about the anaphylaxis treatment market with figures data tables and table of contents. You can also find detailed market segmentation at https://www.factmr.com/report/3417/anaphylaxis-treatment-market

Competitive Landscape

Major players in the anaphylaxis treatment market include but are not limited to Adamis Pharmaceutical Corporation, ALK-Abello, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Merck & Co. Inc., Mylan N.V., Amneal Pharmaceuticals, and GlaxoSmithKline Plc.

Leading players participating in the anaphylaxis treatment market are increasingly focusing on research and development efforts including major clinical trials for drug development and therapeutics. Strategic agreements for better scope of commercialization supports market growth efforts.

In February 2021, Bryn Pharma LLC announced positive results for a multi-dose study for BRYN-NDS1C, an epinephrine nasal spray for both short- and long-term pharmacokinetic outcomes as compared to injector alternatives.

Hoth Therapeutics Inc. a leading biopharmaceutical market player announced the expansion of its licensing agreement with the North Carolina State University including the development and commercialization of treatments for anaphylaxis and mast cell cancers worldwide.

More Insights on the Anaphylaxis treatment Market

In its latest report, Fact.MR offers unbiased analysis of the global anaphylaxis treatment market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of medication type (epinephrine, antihistamines, steroids, beta-agonist, H2 blockers, vasodilators, and others), route of administration (oral, parenteral, and others), allergy type (food allergy, medications, insect stings, latex allergy, and others), and distribution channel (hospital pharmacies, retail sales, drug store, mail order pharmacies) across seven regions (North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa).

Request more information about Report Methodology

https://www.factmr.com/connectus/sample?flag=RM&rep_id=3417

Explore Fact.MR’s Coverage on the Healthcare Domain

Analytical Gel Permeation Chromatography Market: A recent study by Fact.MR on the analytical gel permeation chromatography market offers an 8-year forecast analysis for the period 2018 to 2026. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Pediatric Orthotics Market: Fact.MR’s extensive coverage on the pediatric orthotics market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Veterinary Tables Market: The global veterinary tables imaging market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Source: Fact.MR

Back to news